Skip to site menu Skip to page content
Curia Global
Go back
Download Product

Thank you.

Please check your email to download the Product.

High Potency

As drug pipelines shift toward increasingly potent molecules, safe containment and specialised handling have become essential to successful development and manufacturing. Curia offers dedicated high-potency capabilities designed to support the production of cytotoxic and other highly active compounds, from early development quantities through large-scale commercial supply.

Backed by three decades of experience, Curia’s SafeBridge®-certified facilities are engineered to manage materials requiring stringent occupational exposure controls, including compounds down to OEB4 and OEB5 classifications. The company’s infrastructure combines isolator-based processing, specialised reactor systems, and particle-size reduction technologies to enable safe, reproducible manufacturing across the product lifecycle. Curia’s teams bring deep expertise across demanding applications, including oncology compounds, antibody drug conjugate payloads, steroids, and hormones.

Whether guiding a first-time high-potency programme or supporting an established project, Curia provides the flexibility, technical depth, and containment expertise needed to advance complex molecules with confidence, delivering integrated support from development through commercial-scale production.

Related Content